Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1994 Sep;85(9):904–910. doi: 10.1111/j.1349-7006.1994.tb02967.x

p53 Gene Mutations in Human Prostate Cancers in Japan: Different Mutation Spectra between Japan and Western Countries

Masatoshi Watanabe 1,✉, Toshikazu Ushijima 1, Hideki Kakiuchi 1, Taizo Shiraishi 2, Ryuichi Yatani 2, Jun Shimazaki 3, Toshihiko Kotake 4, Takashi Sugimura 1, Minako Nagao 1
PMCID: PMC5919581  PMID: 7961118

Abstract

The involvement of p53 mutations in prostate cancers in Japan was investigated. To evaluate any possible clinicopathological significance, p53 mutations in 40 samples from 36 Japanese prostate cancers of different stages (five cases of latent tumors, three of stage A cancers, 10 of stage B, five of stage C and 13 of stage D), including four lymph node metastases of stage D cases, were examined by polymerase chain reaction‐single strand conformation polymorphism (PCR‐SSCP) analysis and sequencing. Mutations were detected in five of 40 samples (12.5%); four were in primary cancers and the other in a lymph node metastasis from one of them. All mutation‐positive cases were in stage D, and the mutation frequency in stage D cases was 31%. This result indicates that p53 mutations may play a role in the progression of a subgroup of prostate cancers in Japanese, as observed for Americans and Europeans. However, a difference was noted between Japanese and Americans in the p53 mutational spectrum (at CpG site), presumably arising from variation in the underlying etiotogic factors.

Keywords: p53 mutation, Prostate cancer, PCR‐SSCP

Full Text

The Full Text of this article is available as a PDF (431.8 KB).

REFERENCES

  • 1. ) Gittes , R. F.Carcinoma of the prostate , N. Engl. J. Med. , 324 , 236 – 245 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Silverberg , E. , Boring , C. C. and Squires , T. S.Cancer statistics 1990 . Ca Cancer J. Clin. , 40 , 9 – 26 ( 1990. ). [PubMed] [Google Scholar]
  • 3. ) Zaridze , D. G. and Boyle , P.Cancer of the prostate: epidemiology and aetiology . Br. J. Urol , 59 , 493 – 502 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Waterhouse , J. , Muir , C. , Shanmugaratnam , K. and Powell , J.“Cancer Incidence in Five Continents, Vol. 4,” IARC Scientific Publications, No. 42, p. 746 ( 1982. ). International Agency for Research on Cancer; , Lyon . [Google Scholar]
  • 5. ) Statistics and Information Department, Ministry of Health and Welfare . “Vital Statistics 1991 Japan,” pp. 266 – 271 ( 1993. ). Health and Welfare Statistics Association; , Tokyo . [Google Scholar]
  • 6. ) Yatani , R. , Chigusa , I. , Akazaki , K. , Stmmermann , G. N. , Welsh , R. A. and Correa , P.Geographic pathology of latent prostatic carcinoma . Int. J. Cancer , 29 , 611 – 616 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Carter , B. S. , Carter , H. B. and Isaacs , W. B.Epidemiologic evidence regarding predisposing factors to prostate cancer . Prostate , 16 , 187 – 197 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Nakazawa , H. , English , D. , Randell , P. , Nakazawa , K. , Martel , N. , Armstrong , B. K. and Yamasaki , H.UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement . Proc. Natl Acad, Set. USA , 91 , 360 – 364 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Bressac , B. , Kew , M. , Wands , J. and Ozturk , M.Selective G to T mutations of the p53 gene in hepatocellular carcinomas from southern Africa . Nature , 350 , 429 – 432 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Moul , J. W. , Friedrichs , P. A. , Lance , R. S. , Theune , S. M. and Chang , E. H.Infrequent ras oncogene mutations in human prostate cancer . Prostate , 20 , 327 – 338 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Carter , B. S. , Epstein , J. I. and Isaacs , W. B.ras gene mutations in human prostate cancer . Cancer Res. , 50 , 6830 – 6832 ( 1990. ). [PubMed] [Google Scholar]
  • 12. ) Gumerlock , P. H. , Poonamallee , U. R. , Meyers , F. J. and de Vere White , R. W.Activated ras alleles in human carcinoma of the prostate are rare . Cancer Res. , 51 , 1632 – 1637 ( 1991. ). [PubMed] [Google Scholar]
  • 13. ) Peehl , D. M. , Wehner , N. and Stamey , T. A.Activated Ki‐ras oncogene in human prostatic adenocarcinoma . Prostate , 10 , 281 – 289 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Anwar , K. , Nakakuki , K. , Shiraishi , T. , Naiki , H. , Yatani , R. and Innuzuka , M.Prevalence of ras oncogene mutations and human papilloma virus DNA in human prostatic carcinoma . Cancer Res. , 52 , 5991 – 5996 ( 1991. ). [PubMed] [Google Scholar]
  • 15. ) Isaacs , W. B. , Carter , B. S. and Ewing , C. M.Wild‐type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles . Cancer Res. , 51 , 4716 – 4720 ( 1991. ). [PubMed] [Google Scholar]
  • 16. ) Mellon , K. , Thompson , S. , Charlton , R. G. , Marsh , C. , Robinson , M. , Lane , D. P. , Harris , A. L. , Home , C. H. and Neal , D. E.p53, c‐erbB‐2 and the epidermal growth factor receptor in the benign and malignant prostate . J. Urol , 147 , 496 – 499 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Soini , Y. , Paakko , P. , Nuorva , K. , Kamel , D. , Lane , D. P , and Vahakangas , K.Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas . Virchows Arch. A Pathol. Anal. Histopathol. , 421 , 223 – 228 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) Effert , P. J. , McCoy , R. H. , Walther , P. J. and Liu , E. T.p53 gene alterations in human prostate carcinoma . J, Urol. , 150 , 257 – 261 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Effert , P. J. , Neubauer , A. , Walther , P. J. and Liu , E. T.Alterations of the p53 gene are associated with the progression of a human prostate carcinoma . J. Urol. , 147 , 789 – 793 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Bookstein , R. , MacGrogan , D. , Hilsenbeck , S. G. , Sharkey , F. and Allred , D. C.p53 is mutated in a subset of advanced‐stage prostate cancer . Cancer Res. , 53 , 3369 – 3373 ( 1993. ). [PubMed] [Google Scholar]
  • 21. ) Navone , N. M. , Troncoso , P. , Pisters , L. L. , Goodrow , T. L. , Palmer , J. L. , Nichols , W. W. , von Eschenbach , A. C. , and Conti , C. J.p53 protein accumulation and gene mutation in the progression of human prostate carcinoma . J. Natl. Cancer Inst , 85 , 1657 – 1669 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Uchida , T. , Wada , C. , Shitara , T. , Egawa , S. and Koshiba , K.Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer . Br. J. Cancer , 68 , 751 – 755 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Japanese Urological Association and The Japanese Pathological Society . “The General Rules for Clinical and Pathological Studies on Prostatic Cancer,” 2nd Ed. , pp. 40 – 46 ( 1992. ). Kanehara Press; , Tokyo . [Google Scholar]
  • 24. ) Gleason , D. F. and Mellinger , G. T.Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging . J. Urol. , 111 , 58 – 64 ( 1974. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Sambrook , J. , Fritsch , E. F. and Maniatis , T.Isolation of high‐molecular‐weight DNA from mammalian cells . In“Molecular Cloning,” ed. Ford N. N.C. and Ferguson M. , pp. 914 – 923 ( 1989. ). Cold Spring Harbor Laboratory Press; , New York . [Google Scholar]
  • 26. ) Higuchi , R.Simple and rapid preparation of samples for PCR . In“PCR Technology,” ed. Erlich H. A. , pp. 31 – 43 ( 1989. ). Stockton Press; , New York . [Google Scholar]
  • 27. ) Buchman , V. L. , Chumakov , P. M. , Ninkina , N. N. , Samarina , O. P. and Georgiev , G. P.A variation in the structure of the protein‐coding region of the human p53 gene . Gene , 70 , 245 – 252 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Hsu , I. C. , Metcalf , R. A. , Sum , T. , Welsh , J. A. , Wang , N. J. and Harris , C. C.Mutational hotspot in the p53 gene in human hepatocellular carcinomas . Nature , 350 , 427 – 448 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Nose , H. , Imazeki , P. , Ohto , M. and Omata , M.p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan . Cancer , 72 , 355 – 360 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Vogan , K. , Bernstein , M. , Leclerc , J.‐M. , Brisson , L. , Brossard , J. , Brodeur , G. M. , Pelletier , J. and Gros , P.Absence of p53 gene mutations in primary neuroblastomas . Cancer Res. , 53 , 5269 – 5273 ( 1993. ). [PubMed] [Google Scholar]
  • 31. ) Glavac , D. and Dean , M.Optimization of the singlestrand conformation polymorphism (SSCP) technique for detection of point mutations . Hum. Mutat. , 2 , 404 – 414 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 53 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Dinjens , W. N. M. , Van der Weiden , M. M. , Schroeder , F. H. , Bosnian , F. T. and Trapman , J.Frequency and characterization of p53 mutations in primary and meta‐static human prostate cancer . Int. J. Cancer , 56 , 630 – 633 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Kallakury , B. V. S. , Figge , J. , Ross , J. S. , Fischer , H. A. G. , Figge , H. L. and Jennings , T. A.Association of p53 immunoreactivity with high Gleason tumor grade in prostatic adenocarcinoma . Hum. Pathol. , 25 , 92 – 97 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Thomas , D. J. , Robinson , M. , King , P. , Hasan , T. , Charlton , R. , Martin , J. , Carr , T. W. and Neal , D. E.p53 expression and clinical outcome in prostate cancer . Br. J. Cancer , 12 , 778 – 781 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Paraskeva , C. , Markowitz , S. , Wilison , J. K. V. , Hamilton , S. and Vogelstein , B.p53 gene mutations in combination with 17p allelic deletions as late events in colorectal tumorigenesis . Cancer Res. , 50 , 7717 – 7722 ( 1990. ). [PubMed] [Google Scholar]
  • 37. ) Sameshima , Y. , Matsuo , Y. , Hirohashi , S. , Shimosato , Y. , Mizoguchi , H. , Sugimura , T. , Terada , M.Yokota , J.Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small‐cell lung carcinoma . Oncogens , 7 , 451 – 457 ( 1992. ). [PubMed] [Google Scholar]
  • 38. ) Fujimoto , K. , Yamada , Y. , Okajima , E. , Kakizoe , T. , Sasaki , H. , Sugimura , T. and Terada , M.Frequent association of p53 gene mutation in invasive bladder cancer . Cancer Res. , 52 , 1393 – 1398 ( 1992. ). [PubMed] [Google Scholar]
  • 39. ) Coles , C. , Condie , A. , Chetty , U. , Steel , M. , Evans , H. J. and Prosser , J.p53 mutations in breast cancer . Cancer Res. , 52 , 5291 – 5298 ( 1992. ). [PubMed] [Google Scholar]
  • 40. ) Wink , D. A. , Kasprzak , K. S. , Maragos , C. M. , Elespuru , R. K. , Misra , M. , Dunams , T. M. , Cebula , T. A. , Koch , W. H. , Andrews , A. W. , Allen , J. S. and Keefer , L. K.DNA deaminating ability and genotoxicity of nitric oxide and its progenitors . Science , 254 , 1001 – 1003 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Konishi , N. , Enomoto , T. , Buzard , G. , Ohshima , M. , Ward , J. M. and Rice , J. M.K‐ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men . Cancer , 69 , 2293 – 2299 ( 1992. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES